NPI: 1639151301 · LAFOLLETTE, TN 37766 · General Acute Care Hospital · NPI assigned 11/17/2005
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 11/17/2005 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 36,868 | $1.62M |
| 2019 | 41,966 | $1.65M |
| 2020 | 28,755 | $1.23M |
| 2021 | 27,035 | $1.48M |
| 2022 | 29,414 | $1.60M |
| 2023 | 29,617 | $1.42M |
| 2024 | 21,390 | $1.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 20,696 | 18,126 | $4.01M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,408 | 11,221 | $2.98M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5,765 | 4,653 | $1.36M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,025 | 2,698 | $386K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,975 | 1,805 | $275K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,852 | 1,698 | $184K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,644 | 5,044 | $123K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,503 | 7,064 | $110K |
| G0378 | Hospital observation service, per hour | 1,000 | 441 | $80K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 346 | 238 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 23,453 | 18,050 | $61K |
| 84484 | 8,963 | 6,028 | $54K | |
| 80053 | Comprehensive metabolic panel | 21,088 | 16,664 | $45K |
| 71045 | Radiologic examination, chest; single view | 10,382 | 8,137 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,537 | 1,268 | $28K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,753 | 3,071 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,796 | 4,305 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,914 | 2,391 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,538 | 7,336 | $22K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,003 | 2,465 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 308 | 264 | $16K |
| 36415 | Collection of venous blood by venipuncture | 16,201 | 11,799 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 737 | 652 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,726 | 2,354 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,935 | 1,799 | $7K |
| 83690 | 2,697 | 2,285 | $7K | |
| 94060 | 199 | 162 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 581 | 380 | $6K |
| 81001 | 8,818 | 7,588 | $5K | |
| 87070 | 1,354 | 1,252 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | 953 | 735 | $4K |
| 81025 | 2,229 | 2,051 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 270 | 168 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 103 | 36 | $4K |
| 97597 | 135 | 67 | $3K | |
| 83880 | 670 | 510 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,466 | 1,153 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 313 | 246 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 88 | 72 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 56 | 25 | $2K |
| 87040 | 600 | 371 | $2K | |
| 94729 | 217 | 183 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 85 | 37 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 302 | 264 | $2K |
| 80061 | Lipid panel | 868 | 787 | $2K |
| 86403 | 414 | 396 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 109 | 86 | $2K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 13 | 12 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 46 | 43 | $1K |
| 94727 | 176 | 146 | $1K | |
| 83605 | 487 | 375 | $1K | |
| 74178 | 17 | 14 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 31 | 25 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | 288 | 264 | $954.82 |
| 85027 | 991 | 789 | $953.52 | |
| 72100 | 61 | 44 | $872.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 453 | 351 | $865.85 |
| 93017 | 55 | 39 | $770.77 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 20 | 12 | $600.36 |
| 87400 | 73 | 49 | $598.61 | |
| 87081 | 235 | 220 | $595.53 | |
| 82550 | 409 | 321 | $585.20 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 32 | 32 | $513.15 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 329 | 264 | $504.97 |
| 83735 | 298 | 217 | $493.19 | |
| 85610 | 315 | 255 | $404.42 | |
| 85379 | 107 | 86 | $399.92 | |
| 82150 | 111 | 94 | $323.11 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 13 | 12 | $316.58 |
| 83036 | Hemoglobin; glycosylated (A1C) | 210 | 192 | $291.32 |
| 84439 | 136 | 123 | $261.79 | |
| 82803 | 70 | 52 | $242.46 | |
| 96376 | 70 | 25 | $227.68 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 19 | 12 | $220.82 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 78 | 48 | $193.99 |
| 85730 | 162 | 125 | $167.21 | |
| 82962 | 128 | 24 | $159.83 | |
| 82607 | 110 | 101 | $155.99 | |
| 36600 | 70 | 52 | $122.64 | |
| 71271 | 21 | 15 | $103.13 | |
| 74022 | 17 | 15 | $89.12 | |
| 94761 | 16 | 12 | $88.48 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 27 | 24 | $72.29 |
| 86140 | 25 | 20 | $63.57 | |
| 87807 | 12 | 12 | $55.36 | |
| 82728 | 27 | 27 | $44.52 | |
| 82746 | 12 | 12 | $24.03 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 34 | 30 | $22.02 |
| 81003 | 13 | 12 | $17.05 | |
| 82565 | 15 | 13 | $11.16 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 66 | 46 | $9.89 |
| 84100 | 18 | 12 | $7.68 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,383 | 4,273 | $4.60 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,840 | 1,573 | $0.00 |
| 88342 | 53 | 41 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 519 | 453 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 1,122 | 801 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 14 | 12 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 190 | 146 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 33 | 26 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 110 | 82 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 725 | 575 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 32 | 29 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19 | 16 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 14 | 12 | $0.00 |